Athira Pharma logo

Athira Pharma

ATHANASDAQ

Athira Pharma is a biotechnology company in the healthcare sector on NASDAQ, led by Mark Litton, with a market cap of $15.2M. As of Q3 2025, 43% of shares are held by 32 institutional investors, with PERCEPTIVE ADVISORS LLC as the largest holder at 13.7%.

President and Chief Executive OfficerMark Litton
Market Cap$15.2M
Biotechnology
Healthcare
Employees67.0
Websiteathira.com
Country
United States of America

Overview

Overview of institutional ownership in ATHA as of Q3 2025 with a market cap of $16.3M

All Institutions

Institutions
32
Value Held
$7.1M
Shares Held
1.7M
Avg Position
$220.9K
Median Position
$43.1K

Hedge Funds

Hedge Funds
5
Value Held
$3.3M
Shares Held
790.3K
Avg Position
$654.4K
Median Position
$215.0K

Ownership Breakdown

Institutional (non-HF): 23.25%Institutional (non-HF)Hedge Funds: 20.04%Hedge FundsRetail & Other: 56.71%Retail & Other
Institutional (non-HF)
23.25%
$3.8M
Hedge Funds
20.04%
$3.3M
Retail & Other
56.71%
$9.3M

Based on market cap of $16.3M as of Q3 2025. Institutional (non-HF) excludes hedge funds to avoid double counting.

Biggest Investors

Institutions with the largest positions in ATHA as of Q3 2025

InstitutionPosition Value
PERCEPTIVE ADVISORS LLC logo
PERCEPTIVE ADVISORS LLC
Hedge FundLong/Short
$2.2M
0.06% of portfolio
$1.3M
1.21% of portfolio
$636.7K
0.00% of portfolio
Propel Bio Management, LLC logo
Propel Bio Management, LLC
Hedge FundSector
$618.0K
0.62% of portfolio
$618.0K
0.04% of portfolio
$248.4K
0.01% of portfolio
$215.0K
0.00% of portfolio
$166.4K
0.00% of portfolio
$159.8K
0.00% of portfolio
B
BlackRock, Inc.
Institution
$155.8K
0.00% of portfolio

Net Capital Flow

Institutional buying and selling activity for ATHA in Q3 2025

Traded
$9.6K
Buyers
9
Sellers
39
Total Bought
+$236.5K
Total Sold
$246.1K
Avg Position
$138.6K

Biggest Buyers

InstitutionNet Bought
+$115.2K
+27.8K shares
CITADEL ADVISORS LLC logo
CITADEL ADVISORS LLC
Hedge FundMulti-Strategy
+$53.7K
+13.0K shares
+$53.5K
+12.9K shares
+$7.5K
+2.0K shares
+$5.7K
+1.4K shares
UBS Group AG logo
UBS Group AG
Institution
+$596.0
+-20.2K shares
+$215.4
+52.1 shares
BARCLAYS PLC logo
BARCLAYS PLC
Institution
+$27.3
+6.6 shares
CITIGROUP INC logo
CITIGROUP INC
Institution
+$4.0
+1.0 shares

Biggest Sellers

InstitutionNet Sold
$58.2K
19.3K shares
$37.3K
9.0K shares
$16.2K
5.4K shares
Clarius Group, LLC logo
Clarius Group, LLC
Family Office
$16.2K
5.4K shares
X
XTX Topco Ltd
Institution
$16.0K
5.3K shares
$16.0K
5.3K shares
$10.9K
2.6K shares
EWA, LLC logo
EWA, LLC
RIA/Wealth
$10.8K
3.6K shares
$9.7K
3.2K shares
$7.5K
2.5K shares

Entry and Exit Activity

Institutions that initiated new positions or completely exited ATHA in Q3 2025

New Positions
0
New Value
-
Exited Positions
18
Exited Value
$192.4K

New Positions

InstitutionPosition Value
No new positions found

Exited Positions

InstitutionPrevious Position
$58.2K
19.3K shares
$16.2K
5.4K shares
Clarius Group, LLC logo
Clarius Group, LLC
Family Office
$16.2K
5.4K shares
X
XTX Topco Ltd
Institution
$16.0K
5.3K shares
$16.0K
5.3K shares
EWA, LLC logo
EWA, LLC
RIA/Wealth
$10.8K
3.6K shares
$9.7K
3.2K shares
$7.5K
2.5K shares
$6.2K
2.1K shares
$6.2K
2.1K shares

Options Activity

Institutions with the largest Call and Put options positions in ATHA as of Q3 2025

Call Positions
1
Call Value
-
Put Positions
0
Put Value
-

Call Positions

InstitutionPosition Value
CITADEL ADVISORS LLC logo
CITADEL ADVISORS LLC
Hedge FundMulti-Strategy
-
- contracts

Put Positions

InstitutionPosition Value
No put positions found

Most Committed Institutions

Institutions with ATHA as the highest % of their portfolio as of Q3 2025

InstitutionPortfolio Weight
1.21%
$1.3M
Propel Bio Management, LLC logo
Propel Bio Management, LLC
Hedge FundSector
0.62%
$618.0K
PERCEPTIVE ADVISORS LLC logo
PERCEPTIVE ADVISORS LLC
Hedge FundLong/Short
0.06%
$2.2M
0.04%
$618.0K
0.01%
$248.4K
0.01%
$41.8K
0.00%
$159.8K
0.00%
$828.0
0.00%
$166.4K
0.00%
$215.0K

Hedge Fund Spotlight

Discover hedge funds investing in ATHA

TWO SIGMA ADVISERS, LLC logo
TWO SIGMA ADVISERS, LLC
Hedge FundMulti-Strategy
Portfolio ManagerScott David Hoffman
Portfolio Value
$50.0B
Positions
2,312
Last Reported
Q3 2025
AddressNew York, NY
Sector Allocation
Technology: 26.00%TechnologyFinancial Services: 16.30%Financial ServicesHealthcare: 11.10%HealthcareConsumer Cyclical: 10.90%Consumer CyclicalIndustrials: 10.00%IndustrialsCommunication Services: 6.60%Consumer Defensive: 6.30%Energy: 3.20%Basic Materials: 2.30%Utilities: 1.80%Real Estate: 1.30%
Athira Pharma logo

Position in Athira Pharma

Market Value
$61.5K
Shares Held
14.9K
Portfolio Weight
0.00%
Owned Since
2020-Q4
Top HoldingSectorMarket ValueWeight
1
Nvidia logo
Nvidia
NVDA
Semiconductors
Technology
$1.5B3.07%
Software - Infrastructure
Technology
$1.5B3.03%
3
Apple logo
Apple
AAPL
Consumer Electronics
Technology
$1.4B2.79%

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.